1. Home
  2. BCPC vs PLXS Comparison

BCPC vs PLXS Comparison

Compare BCPC & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Balchem Corporation

BCPC

Balchem Corporation

HOLD

Current Price

$173.25

Market Cap

5.5B

Sector

Industrials

ML Signal

HOLD

PLXS

Plexus Corp.

HOLD

Current Price

$200.79

Market Cap

5.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCPC
PLXS
Founded
1967
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Electrical Products
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.3B
IPO Year
N/A
1986

Fundamental Metrics

Financial Performance
Metric
BCPC
PLXS
Price
$173.25
$200.79
Analyst Decision
Buy
Buy
Analyst Count
2
4
Target Price
$176.00
$194.00
AVG Volume (30 Days)
156.7K
377.1K
Earning Date
02-20-2026
01-28-2026
Dividend Yield
0.55%
N/A
EPS Growth
22.48
49.29
EPS
4.57
6.43
Revenue
$1,013,548,000.00
$4,126,696,000.00
Revenue This Year
$10.41
$10.99
Revenue Next Year
$6.36
$7.02
P/E Ratio
$38.10
$30.51
Revenue Growth
7.55
4.36
52 Week Low
$139.17
$103.43
52 Week High
$177.40
$208.92

Technical Indicators

Market Signals
Indicator
BCPC
PLXS
Relative Strength Index (RSI) 68.11 69.32
Support Level $167.80 $193.49
Resistance Level $176.35 $208.92
Average True Range (ATR) 3.41 9.51
MACD 0.46 1.72
Stochastic Oscillator 75.78 78.14

Price Performance

Historical Comparison
BCPC
PLXS

About BCPC Balchem Corporation

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

About PLXS Plexus Corp.

Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.

Share on Social Networks: